Objectives: (1) To investigate the extent to which family physicians (GPs) in Lithuania inform their patients about possible side-effects when a common treatment is proposed. (2) To examine the relation between physicians’ estimation of the severity and frequency of these side-effects and their willingness to inform patients. (3) To identify the reasons for informing or not informing the patients.
Methods: A questionnaire, presenting three hypothetical cases involving decisions about ordinary medical treatments and a series of general questions about information about side-effects, was distributed to 500 Lithuanian GPs. The response rate was 42%.
Results: The respondents differed considerably with regard to their willingness to inform patients about side-effects, but they informed their patients significantly more if the side effect was considered to be common and serious, than in cases when it was considered to be rare and trivial. The majority of the respondents informed their patients primarily to enable them to react appropriately to the side-effects in question. The major reason for not informing was that the side-effects were considered too rare to be relevant to the patient’s decision-making.
Conclusion: Information, given to patients about side-effects by Lithuanian GPs, is not in accordance with the principle of respect for patients’ autonomy and requirements of Lithuanian legislation.
- general practitioners
- adverse effects
- informed consent
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- Diagnosis and management of premenstrual disorders
- Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments
- Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study
- Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment
- What determines whether patients are willing to participate in resuscitation studies requiring exception from informed consent?
- Ethical issues in psychopharmacology
- Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis
- Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa
- Psychosocial aspects of the functional gastrointestinal disorders
- Is greater patient involvement associated with higher satisfaction? Experimental evidence from a vignette survey